Drugmaker Pfizer’s Q2 earnings showed mixed results. EPS beat analyst expectations but revenue declined on falling demand for its COVID products.
Pfizer Q2 Revenue Misses Expectations as COVID Product Demand Slumps
August 1, 2023
76 Views
1 Min Read